<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02443610</url>
  </required_header>
  <id_info>
    <org_study_id>HEMOTHEPP ( RB 13.175)</org_study_id>
    <nct_id>NCT02443610</nct_id>
  </id_info>
  <brief_title>Haemorrhages and Thromboembolic Venous Disease of the Postpartum</brief_title>
  <acronym>HEMOTHEPP</acronym>
  <official_title>Hémorragies et Maladie Veineuse Thromboembolique du Post-partum : Epidémiologie, Etudes Des déterminants Cliniques et Biologiques</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Brest</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Brest</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The aim of this study is to evaluate the frequencey and the determinants of postpartum major
      complications (hemorrhage and thrombosis) up to 3 months after delivery in the maternity
      hospitals of Finistère (Bretagne - France)
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      This is an analytical observational prospective multicenter cohort study , conducted on all
      the maternity hospitals in Finistère (Bretagne - France), with a biological collection.

      This protocol allows to study all women at risk of PPH (Postpartum Hemorrhage) and postpartum
      venous thromboembolic disease, including maternity level 1-3 without case selection. The
      prospective nature of the study should provide a more detailed analysis of exposures in this
      particular population of women (risk factors related to the field, childbirth, the postpartum
      events ...).

      The events of interest were PPH and venous thromboembolic disease.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>June 2015</start_date>
  <completion_date type="Anticipated">June 2017</completion_date>
  <primary_completion_date type="Anticipated">June 2017</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Postpartum Hemorrhage</measure>
    <time_frame>2 days</time_frame>
    <description>Volume of blood loss up to 48 hours after delivery and / or weight compresses collected at delivery, and / or diagnosis of the clinician</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Symptomatic thromboembolic events</measure>
    <time_frame>3 month</time_frame>
  </primary_outcome>
  <enrollment type="Anticipated">20000</enrollment>
  <condition>Postpartum Hemorrhage</condition>
  <condition>Venous Thromboembolism</condition>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Blood samples
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        All women admitted for delivery in a maternity Finistère
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Any woman giving birth and supported in one of Gynaecology Obstetrics services of a
             maternity Finistere.

          -  Women ≥ 16 at the time of the collection of non-opposition.

          -  For minor patients: understanding the patient and at least one parent.

          -  All births ≥ 15 weeks gestation.

        Exclusion Criteria:

          -  Home Birth

          -  Expressed opposition to participation in this study.

          -  Childbirth under X.

          -  Parent (s) uninformed of the pregnancy of their child.
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>16 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>PAN PETESCH Brigitte</last_name>
    <role>Principal Investigator</role>
    <affiliation>Unité d'Hémostase , Centre Régional de traitement de l'hémophilie et des maladies hémorragiques, CHRU de Brest (France)</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>CHRU de Brest - Service de Gynécologie-obstétrique</name>
      <address>
        <city>Brest</city>
        <zip>29609</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>DUPRE Pierre-François Pierre-François</last_name>
      <phone>02 98 22 34 23</phone>
      <email>pierre-francois.dupre@chu-brest.fr</email>
    </contact>
    <investigator>
      <last_name>DUPRE Pierre-François</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Clinique Keraudren</name>
      <address>
        <city>Brest</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>SALNELLE Gilles</last_name>
      <phone>02 98,; 34 24 70</phone>
      <email>gilles.salnelle@wanadoo.fr</email>
    </contact>
    <investigator>
      <last_name>SALNELLE Gilles</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Carhaix</name>
      <address>
        <city>Carhaix</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MARGIS Denis</last_name>
      <phone>02 98 99 23 90</phone>
      <email>denis.margis@chu-brest.fr</email>
    </contact>
    <investigator>
      <last_name>MARGIS Denis</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Landerneau</name>
      <address>
        <city>Landerneau</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>COLLET Michel</last_name>
      <phone>02 98 22 33 98</phone>
      <email>michel.collet@chu-brest.fr</email>
    </contact>
    <investigator>
      <last_name>COLLET Michel</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH de Morlaix</name>
      <address>
        <city>Morlaix</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>MULLER Matthieu</last_name>
      <phone>02 98 62 60 77</phone>
      <email>mmuller@ch-morlaix.fr</email>
    </contact>
    <investigator>
      <last_name>MULLER Matthieu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>CH Quimper</name>
      <address>
        <city>Quimper</city>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>JACQUOT Matthieu</last_name>
      <phone>02 98 52 61 05</phone>
      <email>mjacquot@ch-cornouaille.fr</email>
    </contact>
    <investigator>
      <last_name>JACQUOT Matthieu</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>April 2016</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>May 5, 2015</study_first_submitted>
  <study_first_submitted_qc>May 11, 2015</study_first_submitted_qc>
  <study_first_posted type="Estimate">May 14, 2015</study_first_posted>
  <last_update_submitted>April 28, 2016</last_update_submitted>
  <last_update_submitted_qc>April 28, 2016</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 29, 2016</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Postpartum Hemorrhage</keyword>
  <keyword>Venous Thromboembolism</keyword>
  <keyword>Pregnancy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hemorrhage</mesh_term>
    <mesh_term>Thromboembolism</mesh_term>
    <mesh_term>Venous Thromboembolism</mesh_term>
    <mesh_term>Postpartum Hemorrhage</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

